abstract |
(A) an immunoconjugate comprising a first antibody and an effector moiety engineered to have reduced effector function and (b) an enhanced effector function, Lt; RTI ID = 0.0 > 2 < / RTI > Also provided are pharmaceutical compositions comprising the combination and methods of using the same. |